| Wafaa El-Sadr, MD, MPH is the Director of the Center for Infectious Diseases at the
Division of Epidemiology of the Mailman School of Public Health at Columbia University. She is also the Chief of
the Division of Infectious Diseases at Harlem Hospital Center and Professor of Clinical Medicine at Columbia
University and in Public Health. She has long been a leader in TB and HIV research/care, with special interest
in issues related to women, minorities and injection drug users. She is a member of the CDC Advisory Council for
the Elimination of Tuberculosis (ACET). She has extensive experience in participation in multicenter research
networks through the Tuberculosis Treatment Consortium (TBTC) and the Community Programs for Clinical Research
on AIDS (CPCRA), the HIV therapeutic clinical trial network funded by the National Institute of Allergy and
Infectious Diseases. She is a member of the Core Science Group of the TBTC and has participated actively in
the design and implementation of TB-related studies. Dr. El-Sadr is experienced in developing programs that
are both service related and research oriented. She developed the Harlem directly observed therapy program
and the directly observed preventive therapy programs. She is the Director of the Charles P. Felton National
TB Center at Harlem Hospital.
|
|
This Center is dedicated to the development of innovative TB control programs,
training programs and research. She is a site investigator for the Tuberculosis Treatment Consortium, a multicenter
TB clinical trials network funded by the Centers for Disease Control and Prevention. In this capacity, more than 10
TB-related clinical trials are currently ongoing.
She has also been a key participant in the CPCRA through the Harlem AIDS Treatment
Group which has consistently performed well in terms of recruitment of underrepresented populations, achieved
excellent follow-up rates (greater than 97%) and maintained high adherence with performance standards. She has
originated or participated in the development of many research protocols over the past 10 years especially in
the area of the prevention and treatment of opportunistic infections and antiretroviral treatment strategies.
Through NHLBI funding, she developed the Pathways to Completion Study, a clinical trial evaluating several
behavioral interventions for the prevention and treatment of TB. She is the principal investigator of a Prevention
Trials Unit funded by NIAID to conduct HIV prevention studies.
|
